EPO grants second CRISPR patent to ERS Genomics – Life Sciences Intellectual Property Review
Life Sciences Intellectual Property Review |
EPO grants second CRISPR patent to ERS Genomics
Life Sciences Intellectual Property Review The European Patent Office (EPO) has granted a second CRISPR/Cas9 patent to a specialist genomics company, one month after revoking the Broad Institute of Harvard and MIT’s patent relating to the technology. ERS Genomics announced the EPO’s approval of … |
Futurity: Research News |
Scientists control tiny ‘factories’ in engineered cells
Futurity: Research News “Synthetic biology is about making cells easier to engineer so that we can address many of the most important challenges facing us today—from manufacturing new drugs and therapies to finding new biofuels and materials,” says Declan Bates, professor of … |
Futurity: Research News |
Scientists control tiny ‘factories’ in engineered cells
Futurity: Research News “Synthetic biology is about making cells easier to engineer so that we can address many of the most important challenges facing us today—from manufacturing new drugs and therapies to finding new biofuels and materials,” says Declan Bates, professor of … |
|
Unproven Stem Cell Treatments
KFSN-TV Doctors and scientists have made some impressive strides in using stem cells to treat some very complicated diseases, but many unproven therapies are being touted as cure-alls for a large range of illnesses. They often rely on consumers’ hopes for … |